Medical information and safety services

Nordic expertise in pharmacovigilance, medical information and patient support

At Oriola Advisory Services, we offer expert support across pharmacovigilance, medical information and patient support programmes. Our services are designed to help you meet regulatory requirements efficiently, while keeping patient safety and well-being at the centre. With multilingual professionals and in-depth local knowledge, we ensure consistent, compliant delivery in all Nordic countries.

Medical Information services for compliant and multilingual support

Oriola’s medical information services help you meet regulatory requirements while maintaining a high standard of patient safety and customer care. Our multilingual team provides both first-line and second-line support, ensuring timely and compliant responses to product-related queries across the Nordics.

We offer:

• First-line medical information: handling calls, emails and chats; documenting and reporting safety and quality-related data
• Second-line medical information: literature searches in approved databases and preparation of standard responses
• Social media monitoring
• Interim in-house consultants available when needed

Our services are tailored to your needs and can be scaled from individual tasks to fully outsourced solutions.

Pharmacovigilance services across the Nordic countries

At Oriola Advisory Services, patient safety is a top priority. Our pharmacovigilance services are designed to help you meet the requirements set for Marketing Authorisation Holders (MAHs), with compliant and cost-effective support across Finland, Sweden, Norway and Denmark.

We cover the full spectrum of global, local and clinical safety needs:

Global pharmacovigilance

• EU QPPV and deputy QPPV
• Case management
• Quality Management System (QMS) setup
• Pharmacovigilance intelligence
• Creation of risk minimisation plans and periodic reports
• PV auditing

Local pharmacovigilance

• Local safety services
• Local implementation of RMPs and risk minimisation measures (RMMs)
• Local literature review
• Pharmacovigilance intelligence

Clinical safety

• Case management
• SUSARs handling
• Creation and management of aggregated reports

We also provide tailored pharmacovigilance training and interim in-house consultants to support your team.

Patient support programmes with real-world impact

Studies show that about 50% of patients with chronic illnesses do not follow their treatment as prescribed.* Oriola’s patient support programmes are designed to change that. We help patients understand their treatment, use it correctly, and stay motivated to continue – resulting in improved treatment adherence and better outcomes.

As the leading provider of patient support programmes in the Nordics, we offer services suited to all medicinal products and medical devices, especially those with enhanced risk management needs or complex administration.

Our offering includes:

• Dedicated treatment support via phone or digital channels
• Education for patients, families and healthcare professionals
• Online and face-to-face home care
• Home nursing, including treatment and technical support for medical devices
• Flexible service hours across all Nordic countries (Iceland handled separately)

Setting up a support programme can be complex due to the lack of direct legislation. We help you navigate legal, ethical and practical expectations – including patient safety, data protection, cooperation between industry and healthcare, and healthcare provision.

Our goal is to empower patients to become informed and independent users of their treatment and to support their quality of life.

*See e.g. studies related to statin adherence:

https://www.lipidjournal.com/article/S1933-2874(13)00297-3/pdf
https://www.sciencedirect.com/science/article/abs/pii/S0021915015000386
https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.3936
https://www.sciencedirect.com/science/article/pii/S1098301515019804

Other studies:

Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Brixner D, Rubin DT, Mease P, Mittal M, Liu H, Davis M, Ganguli A, Fendrick AM.
J Manag Care Spec Pharm. 2019 Jul;25(7):770-779. doi: 10.18553/jmcp.2019.18443. Epub 2019 May 11.

Compliance in adolescents with chronic disease
Michaud PA, Frappier JY, Pless IB.
Arch Fr Pediatr. 1991 May;48(5):329-36. Review. French.